Literature DB >> 17021888

[Propofol infusion syndrome].

E Trampitsch1, M Oher, I Pointner, R Likar, R Jost, H V Schalk.   

Abstract

The propofol infusion syndrome is a rare but potentially lethal complication resulting from a prolonged continuous administration of propofol. It was first described in the beginning of the 1990's and in recent years there have been frequent reports of problems in association with the use of propofol sedation. The cardinal signs and symptoms of the propofol infusion syndrome are metabolic acidosis, rhabdomyolysis, renal failure, cardiac arrhythmias and a progressive, often therapy-resistant cardiac failure. The pathophysiology of this syndrome appears to involve a disturbance of mitochondrial metabolism induced by propofol. Our report involves a case of propofol infusion syndrome in a patient having undergone cardiac surgery.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17021888     DOI: 10.1007/s00101-006-1085-5

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  15 in total

1.  Lactic acidosis: an early marker of propofol infusion syndrome?

Authors:  Marc Koch; Daniel De Backer; Jean-Louis Vincent
Journal:  Intensive Care Med       Date:  2003-12-19       Impact factor: 17.440

Review 2.  Evaluation of propofol infusion syndrome in pediatric intensive care.

Authors:  Mark P Okamoto; Debra L Kawaguchi; Alpesh N Amin
Journal:  Am J Health Syst Pharm       Date:  2003-10-01       Impact factor: 2.637

3.  Clinical management of cardiogenic shock associated with prolonged propofol infusion.

Authors:  Kimberley E Culp; John G Augoustides; Andrew E Ochroch; Bonnie L Milas
Journal:  Anesth Analg       Date:  2004-07       Impact factor: 5.108

Review 4.  Propofol toxicity in critically ill pediatric patients: show us the proof.

Authors:  G M Susla
Journal:  Crit Care Med       Date:  1998-12       Impact factor: 7.598

5.  Death related to propofol use in an adult patient.

Authors:  N D Perrier; Y Baerga-Varela; M J Murray
Journal:  Crit Care Med       Date:  2000-08       Impact factor: 7.598

6.  Propofol-associated rhabdomyolysis with cardiac involvement in adults: chemical and anatomic findings.

Authors:  E B Stelow; V P Johari; S A Smith; J T Crosson; F S Apple
Journal:  Clin Chem       Date:  2000-04       Impact factor: 8.327

Review 7.  [Propofol infusion syndrome].

Authors:  J Motsch; J Roggenbach
Journal:  Anaesthesist       Date:  2004-10       Impact factor: 1.041

Review 8.  Propofol infusion syndrome in children.

Authors:  R J Bray
Journal:  Paediatr Anaesth       Date:  1998       Impact factor: 2.556

9.  Metabolic acidosis and fatal myocardial failure after propofol infusion in children: five case reports.

Authors:  T J Parke; J E Stevens; A S Rice; C L Greenaway; R J Bray; P J Smith; C S Waldmann; C Verghese
Journal:  BMJ       Date:  1992-09-12

Review 10.  Propofol infusion syndrome in critically ill patients.

Authors:  Tep M Kang
Journal:  Ann Pharmacother       Date:  2002-09       Impact factor: 3.154

View more
  2 in total

1.  [Long-term therapy with propofol has no impact on microcirculation in medical intensive care patients].

Authors:  Christian Jung; Christoph Rödiger; Alexander Lauten; Michael Fritzenwanger; Bjoern Goebel; Julia Schumm; Hans-Reiner Figulla; Markus Ferrari
Journal:  Med Klin (Munich)       Date:  2009-05-16

Review 2.  Metabolic Profiles of Propofol and Fospropofol: Clinical and Forensic Interpretative Aspects.

Authors:  Ricardo Jorge Dinis-Oliveira
Journal:  Biomed Res Int       Date:  2018-05-24       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.